¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hodgkin's disease, mixed cellularity type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
  • Menetrier disease
    ¸Þ³×Æ®¸®¿¡º´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°º´
  • microdrepanocytic disease
    ÀÛÀº³´ÀûÇ÷±¸º´
  • neoplastic disease
    ½Å»ý¹°º´, Á¾¾çº´
  • nervous disease
    ½Å°æ°èÁúȯ, ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±Ù(À°)º´
  • neuropathic joint disease
    ½Å°æº´¼º°üÀýº´
  • notifiable disease
    ½Å°í´ë»óº´, ¹ß»ýº¸°íº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • nutritional disease
    ¿µ¾çº´, ¿µ¾ç¼ºÁúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • occupational disease
    Á÷¾÷º´
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • oculoglandular disease
    ´«»ùº´
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • organic disease
    ±âÁúº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • aortic valvular disease
    ´ëµ¿¸ÆÆÇÁúȯ(¡­òðü´).
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • apocrine miliaria => Fox Fordyce disease
    ¾ÆÆ÷Å©¸° ÇÑÁø
  • arbovirus disease
    ¾Æ¸£º¸¹ÙÀÌ·¯½ºº´(¡­Ü»)
  • arthropod-borne viral disease
    ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½ºº´
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½º,¾Æº¸¹ÙÀÌ·¯½º
  • functional cardiovascular disease
    ±â´É¼º ½ÉÇ÷°üº´.
  • fungous disease
    Áø±ÕÁúȯ, °õÆÎÀÌÆò
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • gastric vertigo =trousseau disease
    À§(¼º)Çö±â
  • gauchers disease
    °í½¦º´, Gaucher º´
  • generalized obstructive lung disease
    ¹ü¹ß¼º Æó¼â¼º ÆóÁúȯ(ÛñÛ¡àõøÍáð
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • spinal type
    ô¼öÇü(ô±âÐúþ).
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • split-electrode-type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ (ÝÂùÜ ï³Ð¿ ÷®õºí­)
  • sthenic type
    ±Ù·ÂÇü(ÐÉæ³úþ).
  • storage-type
    ÃàÀûÇü
  • supporting cell [type ii glomus cell]
    ¹öÆÀ¼¼Æ÷
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü(äâìÔû¡ ÐÝή).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ)
  • thinking type
    »ç°íÇü(ÞÖÍÅúþ).
  • triaxone type
    »ïÃàÇü(ß²õîúþ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆÑÛ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆ )
  • type A behavior
    AÇü Çൿ(ú¼ÔÑ).
  • type A encephalitis
    ±â¸é¼º ³ú¿°(ÐîØùàõÒàæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
MVOS mixed venous oxygen saturation
NML nodular mixed lymphoma
PVCO2 partial pressure of carbon dioxide in mixed venous blood
PVO2 partial oxygen pressure in mixed venous blood
REMA repetitive excess mixed anhydride
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
A.T.C.C. American Type Culture Collection
AT1 Angiotensin II type 1
AT1-R Angiotensin II type 1 receptor
AT1 Angiotensin II receptor type 1
AT1 Angiotensin type 1 receptor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Oguchi's disease
    ¿À±¸Ä¡ º´
    ÀϺ»¿¡¼­ ¹ß°ßÇÑ ¼±Ãµ¼º ¾ß¸ÍÁõÀÇ ÇÑ Çü.
  • Owren's disease
    ¿À¿ì·» º´
    ÀÀ°í ÀÎÀÚ VÀÇ °áÇÌ¿¡ ÀÇÇÑ µå¹® ÃâÇ÷¼º ¼ÒÀÎ, »ó¿°»öü ¿­¼º ¼ÒÁú·Î¼­ À¯ÀüµÈ´Ù.
  • Paas' disease
    ÆÄ½º º´
  • Paget's disease
    ÆÄ°Ù º´, ÆÄÁ¬ Áúȯ, ÆÄÁ¦Æ®º´, º¯Çü¼º °ñ¿°, ÆäÀÌÁ¬¾¾ º´
    1. Çϳª³ª ȤÀº ¿©·¯ °ñÀÇ ¿°ÁõÀ» µ¿¹ÝÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ Àå¾Ö·Î¼­ ¹«Á¶Á÷¼º °ñ ȸº¹À» µ¿¹ÝÇÏ´Â °ñÀÇ ºñÈÄ¿Í ¿¬È­¸¦ ÀÏÀ¸Å²´Ù. 2. À¯¹æÀÇ Pagetº´Àº ¸¸¼º ½ÀÁø°ú À¯»çÇÏ°í ¾ÆÆ÷Å©¸°¼±ÀÌ ¸¹Àº ºÎÀ§¿¡ »ý±ä´Ù. Ç×¹® ÁÖÀ§¿¡ »ý±â´Â °Íº¸´Ù´Â ¿ÜÀ½ºÎ¿¡ »ý±â´Â °Í¿¡¼­ µ¿¹ÝµÈ ÇѼ± ¾ÏÀÌ ÀÖÀ» È®·üÀÌ ¸¹´Ù. À¯¹æÀÇ Pagetº´Àº ÀÏÃø¼º ¶Ç´Â µå¹°°Ô ¾çÃø¼ºÀ¸·Î ¿À´Â È«¹Ý¼º Àμ³¼º ÆÇÀ¸·Î Áø¹°ÀÌ ³¯ ¼ö ÀÖÀ¸¸ç ¶§¶§·Î À¯¹æ¾ÏÀÌ µ¿¹ÝµÈ´Ù. 3. °ñÀÇ ÀÌÇü¼º ÁúȯÀ¸·Î 40´ë ÈĹÝ, ³²¼º¿¡ ´õ ¸¹À¸³ª, ¿©¼º¿¡¼­ ´õ ½ÉÇÏ´Ù. ´Ù°ñ¼ºÀ¸·Î »êÀçÇÏ¿© Àå°ñ°ú ôÃß¿¡ ½ÉÇÑ º´º¯À» ¾ß±âÇÏ¿© º¯Çü°ú ºÒ±¸°¡ µÈ´Ù. µÎ°³°ñ°ú »ó¾Ç°ñÀÌ °úµµÇÏ°Ô ¼ºÀåÇϸç, ¶§·Î´Â ÇϾǰñÀÇ °úµµ ¼ºÀåµµ ÀϾ´Ù. 4. ÆÄ°ñ ¼¼Æ÷¿Í °ñ¸ð ¼¼Æ÷ Ȱ¼ºÀÌ Á¶È­¸¦ ÀÌ·çÁö ¸øÇϸ鼭 Å©±â´Â Ä¿ÁöÁö¸¸ ´õ ¾àÇÑ °ñÀ» ¸¸µå´Â ³ªÀÌµç ¼ºÀο¡¼­ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î µ¿ÅëÀÌ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³ª¸ç, Ç÷û ¾ËÄ«¸®¼º Àλê È¿¼Ò¿Í ÇÏÀ̵å·Ï½Ã ÇÁ·Ñ¸°ÀÌ Áõ°¡µÇ°í ¾Ç¼º °ñ Á¾¾çÀ¸·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ô´Ù.
  • pandemic disease
    ¹üÀ¯Ç༺ º´
    ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ¹ß»ýÇÑ À¯Ç༺ Áúȯ.
  • Parkinsonian disease
    ÆÄŲ½¼¾¾ º´
    1. ¹«¿îµ¿Áõ, ÁøÀü, ±Ù °æÁ÷ÀÌ Æ¯Â¡ÀûÀÎ ½Å°æ Àå¾ÖÀÇ 1±º. 2. Á¤ÁöÇϰí ÀÖÀ» ¶§´Â ÁøÀüÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ÁøÀü ¸¶ºñ.
  • pearl disease
    ÁøÁÖº´
    °¡ÃàÀÇ º¹¸· ¹× Àå°£¸· °áÇÙ.
  • pearl-worker's disease
    ÁøÁÖ°ø º´
    °ñ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â ¹Ýº¹¼º ¿°ÁõÀ¸·Î¼­, ÁøÁÖ ºÐ¸» ¶Ç´Â ¸ÕÁö°¡ ÀÖ´Â Àå¼Ò¿¡¼­ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • Pellegrini's disease
    Æç·¹±×¸®´Ï º´
    ¹«¸­ÀÇ ³»º¹ÃøºÎ Àδë À§¿¡¼­ ¹Ý¿ù»ó °ñ Çü¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­ ¿Ü»ó¼º Àü½Å Àå¾Ö°¡ ¿øÀÎÀÌ´Ù.
  • pelvic inflammatory disease
    °ñ¹Ý¿° Áúȯ
  • peptic ulcer disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
  • peptic ulcerative disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
    Á¤¼­ÀûÀÎ ½ºÆ®·¹½º, ƯÀÌÇÑ À½½Äµé°ú ´Ù¸¥ Á¾·ùÀÇ Àڱص鿡 ÀÇÇØ °úµµÇÑ À§ »êÀÇ ºÐºñ¿¡ ÀÇÇÑ´Ù°í ¹Ï¾îÁø´Ù. °úµµÇÑ ÃâÇ÷, ºóÇ÷, õ°ø µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼öµµ ÀÖ´Ù.
  • periapical disease
    Ä¡±Ù´Ü ÁÖÀ§ Áúȯ
  • pericardial disease
    ½É³¶ Áúȯ, ½É¸· Áúȯ
  • periodontal disease
    Ä¡ÁÖ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
alzheimer disease A degenerative organic mental disease characterised by progressive brain deterioration and dementia. The disease was originally described as dementia, presenile occurring in persons under the age of 65 (as opposed to dementia, senile with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of alzheimer's. Women appear to be affected twice as frequently as men. It is characterised pathologically by the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
(12 Dec 1998)
Alzheimer's disease <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
anaemia of chronic disease <disease> A form of anaemia which develops as the result of a long-term infection or illness. Chronic diseases can interfere with red blood cell production in addition to shortening red blood cell life span in the body.
Symptoms are largely due to the underlying disease. Haemoglobin and haematocrit are generally low. Iron studies may be low to normal. Red blood cell indices may usually normal.
(27 Sep 1997)
anarthritic rheumatoid disease Rheumatoid disease without arthritis.
(05 Mar 2000)
Anders' disease <disease> A disease accompanied by painful localised fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications.
(12 Dec 1998)
Andersen's disease Familial cirrhosis of the liver with storage of abnormal glycogen; glycogenosis due to deficiency of 1,4-alpha-glucan branching enzyme, resulting in accumulation of abnormal glycogen with long inner and outer chains in liver, kidney, muscle, and other tissues.
Synonym: Andersen's disease.
(05 Mar 2000)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
aortoiliac occlusive disease Obstruction of the abdominal aorta and its main branches by atherosclerosis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
Aran-Duchenne disease A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
Aujeszky's disease A highly contagious herpes virus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á